General Information of the m6A Target Gene (ID: M6ATAR00670)
Target Name Protein Wnt-5a (WNT5A)
Gene Name WNT5A
Chromosomal Location 3p14.3
Family Wnt family
Function
Ligand for members of the frizzled family of seven transmembrane receptors. Can activate or inhibit canonical Wnt signaling, depending on receptor context. In the presence of FZD4, activates beta-catenin signaling. In the presence of ROR2, inhibits the canonical Wnt pathway by promoting beta-catenin degradation through a GSK3-independent pathway which involves down-regulation of beta-catenin-induced reporter gene expression (By similarity). Suppression of the canonical pathway allows chondrogenesis to occur and inhibits tumor formation. Stimulates cell migration. Decreases proliferation, migration, invasiveness and clonogenicity of carcinoma cells and may act as a tumor suppressor. Mediates motility of melanoma cells. Required during embryogenesis for extension of the primary anterior-posterior axis and for outgrowth of limbs and the genital tubercle. Inhibits type II collagen expression in chondrocytes (By similarity).
    Click to Show/Hide
Gene ID 7474
Uniprot ID
WNT5A_HUMAN
HGNC ID
HGNC:12784
Ensembl Gene ID
ENSG00000114251
KEGG ID
hsa:7474
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
WNT5A can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
RNA demethylase ALKBH5 (ALKBH5) [ERASER]
Representative RNA-seq result indicating the expression of this target gene regulated by ALKBH5
Cell Line CAG cell line Homo sapiens
Treatment: shALKBH5 CAG cells
Control: shNC CAG cells
GSE180214
Regulation
logFC: -9.66E-01
p-value: 2.63E-04
More Results Click to View More RNA-seq Results
In total 1 item(s) under this regulator
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene [1]
Response Summary ALKBH5 is a negative regulator of post-ischemic angiogenesis via post-transcriptional modulation and destabilization of Protein Wnt-5a (WNT5A) mRNA in an m6A-dependent manner.
Target Regulation Down regulation
Responsed Disease Diseases of the circulatory system ICD-11: BE2Z
In-vitro Model CMECs (Cardiac Microvascular Endothelial Cells )
Diseases of the circulatory system [ICD-11: BE2Z]
In total 1 item(s) under this disease
Experiment 1 Reporting the m6A-centered Disease Response [1]
Response Summary ALKBH5 is a negative regulator of post-ischemic angiogenesis via post-transcriptional modulation and destabilization of Protein Wnt-5a (WNT5A) mRNA in an m6A-dependent manner.
Responsed Disease Diseases of the circulatory system [ICD-11: BE2Z]
Target Regulator RNA demethylase ALKBH5 (ALKBH5) ERASER
Target Regulation Down regulation
In-vitro Model CMECs (Cardiac Microvascular Endothelial Cells )
References
Ref 1 Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A. Clin Transl Med. 2021 May;11(5):e402. doi: 10.1002/ctm2.402.